Sunburn, sunscreen, and melanoma

Current Opinion in Oncology

Volumn 8, Issue 2, 1996, Pages 159-166

  Donawho, Cherrie ^a   Wolf, Peter ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; BENZOPHENONE; CINNAMIC ACID DERIVATIVE; SKIN PROTECTIVE AGENT; SUNSCREEN; TALC; TITANIUM DIOXIDE; ZINC OXIDE;

ANIMAL MODEL; BASAL CELL CARCINOMA; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SEASONAL VARIATION; SKIN CANCER; SKIN CARCINOGENESIS; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; SUNBURN; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

EID: 0029948957     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199603000-00014     Document Type: Review

References (57)

1. Autier P, Doré J-F, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesarini J-P, Liénard D, Liabeuf A, Joarlette M, Chemaly P, Hakim K, Koeln A, Kleeberg UR, for the (EORTC) Malignant Melanoma Cooperative Group: Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma: results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. Melanoma Res 1994, 4:79-85. Exaggerated sun exposure, number of holiday weeks spent annually in sunny resorts, and sunbathing during the hot hours of the day were strong risk factors for melanoma.
2. Whiteman D, Green A: Melanoma and sunburn. Cancer Causes Control 1994, 5:564-572.
3. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ: Cutaneous melanoma in women: I. Exposure to sunlight, ability to tan and other risk factors related to ultraviolet light. Am J Epidemiol 1995, 141:923-933. In this study the risk of all types of cutaneous melanoma increased with a growing tendency to sunburn and with increased severity or frequency of sunburn, from 5 to 6 years to 30 years of age, and sunburns during the 10 years prior to diagnosis.
4. Westerdahl JHO, Ingvar C: At what age do sunburn episodes play a crucial role for the development of malignant melanoma. Eur J Cancer 1994, 30A:1 647-1654. Three sunburns per year was significantly associated with malignant melanoma (RR 1.9). There was a significantly increased risk associated with sunburns after 19 years of age (RR 2.2); five or more sunburns versus none, but no higher risk for individuals who had experienced severe sunburns during childhood.
5. Garbe C, Büttner P, Weib J, Soyer HP, Stocker U, Krüger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I, Orfanos CE: Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lenteigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994, 102:700-705.
6. Garbe C, Büttner P, Weib J, Soyer HP, Stocker U, Krüger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I, Orfanos CE: Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994, 102:695-699.
7. Autier P, Doré J-F, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesarini J-P, Liénard D, Liabeuf A, Joarlette M, Chemaly P, Hakim K, Koeln A, Kleeberg UR, for the (EORTC) Malignant Melanoma Cooperative Group: Cutaneous malignant melanoma and exposure to sun lamps or sun beds: an EORTC multicenter case-control study in Belgium, France and Germany. Int J Cancer 1994, 58:808-813. In this study the melanoma relative risk was 2.12; it was associated with exposure to sun lamps or sun beds before 1980. Subjects who had skin burns and who had 10 or more hours of exposure had a RR of 4.47.
8. Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N, Brandt L, Jonsson PE, Moller T: Use of sunbeds or sunlamps and malignant melanoma in Southern Sweden. Am J Epidemiol 1995, 140:691-699. There was an increased melanoma relative risk of 1.8 for people of all ages after exposure of 10 or more times a year to sunbeds or sunlamps, but the relative risk was 7.7 for people 30 years of age or less.
9. Abadir MC, Marghoob AA, Slade J, Salopek TG, Yadav S, Kopl A: Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. J Am Acad Dermatol 1995, 38:31-36. In this case-control study the melanoma patients were significantly more likely to have melanocytic nevi on their buttocks than the control subjects, but the melanocytic nevi did not differ clinically in number or appearance from those found on the buttocks of controls.
10. Harrison SL, MacLennan R, Speare R, Wronski I: Sun exposure and melanocytic naevi in young Australian children. Lancet 1994, 344:1529-1532.
11. Wolf P, Kripke ML: Sunscreens and immunity. Skin Cancer 1993, 8:33-40.
12. Kricker A, Armstrong BK, English DR, Heenan PJ: Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995, 60:489-494. The investigators' report suggests that BCC and melanoma share both increased association with intermittent teenage sun exposure and sunburn of the site as increased risk factors.
13. Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS: Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma: screening implications. Cancer 1995, 75(suppl 2):707-714. Of 290 patients, there were 72% with BCC, 11% with SCC, and 17% with both BCC and SCC. There was a significant increase in relative risk of 17 for developing melanoma.
14. Braun MM, Tucker MA, Devesa SS, Hoover RN: Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma. Melanoma Res 1994, 4:235-241. The authors studied 32,868 melanoma patients from a 15-year period. They suggested that avoiding excessive exposure to the sun may decrease the risk of melanoma in the short term as well as the long term.
15. Akslen LA: Seasonal variation in melanoma progress [letter]. J Natl Cancer Inst 1995, 87:1025. The authors examined 864 consecutive cases of superficial-spreading malignant melanoma diagnosed from 1981 to 1994; 66% classified as invasive and 34% as in situ. They found a highly significant seasonal pattern in that 55% of invasive tumors were reported in the summer period.
16. Tronnier M, Smolle J, Wolff H: Ultraviolet irradiation induces acute changes in melanocytic nevi. J Invest Dermatol 1995, 104:475-478. The authors investigated the effect of ultraviolet B/ultraviolet A light on melanocytic nevi in vitro and found that a single ultraviolet irradiation may induce transient melanocytic activation with morphologic and histologic changes.
17. Autier P, Doré J-F, Schifflers E, Cesarini J-P, Bollaerts A, Koelmel KF, Geffeler O, Liabeuf A, Lejeune F, Liénard D, Joarlette M, Chemaly P, Kleeberg UR, for the (EORTC) Malignant Melanoma Cooperative Group: Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium, and France. Int J Cancer 1995, 61:749-755. This study is adjusted for age, sex, hair color, and holiday weeks in sunny resorts; cutaneous melanoma was associated with the regular use of common (RR = 1.5) and psoralen (RR = 2.28) sunscreens. The use of sunscreens, especially psoralen sunscreens, was associated with higher density of nevi and freckles of the skin.
18. Klepp O, Magnus K: Some environmental and bodily characteristics of melanoma patients: a case-control study. Int J Cancer 1979, 23:30-35.
19. Graham S, Marshall J, Haughey B: An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985, 122:606-619.
20. Holman CDJ, Armstrong BK, Heenan PJ: Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986, 86:1476-1478.
21. Østerlind A, Tucker MA, Stone BJ, Jensen OM: The Danish case-control study of cutaneous malignant melanoma: II. Importance of UV-light exposure. Int J Cancer 1988, 42:319-324.
22. Beitner H, Norell SE, Ringborg U, Wennersten G, Mattson B: Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol 1990, 122:43-51.
23. Westerdahl J, Olsson H, Måsbäck A, Ingvar C, Jonsson N: Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995, 5:59-65. The use of sunscreens - almost always versus never - was associated with an increased RR of 1.8. A tentative dose-response relationship was found for the frequency of sunscreen use and melanoma risk.
24. Roberts LK, Stanfield JW: Suggestion that sunscreen use is a risk factor is based on inconclusive evidence [letter]. Melanoma Res 1995, 5:377-378.
25. Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC: The effect of regular sunscreen use on vitamin D levels in an Australian population. Archiv Dermatol 1995, 131:415-421. This randomized double blind trial revealed that regular sunscreen use does not lead to D3 levels below the normal range; however, there was significant reduction of solar keratoses with regular sunscreen use.
26. Ainsleigh HG: Beneficial effects of sun exposure on cancer mortality. Prev Med 1993, 22:132-140.
27. Garland FC, White MR, Garland CF, Shaw E, Gorham ED: Occupational sunlight exposure and melanoma in the US Navy. Arch Enivron Health 1990, 45:261-267.
28. Garland CF, Garland FC, Gorham ED: Could sunscreens increase melanoma risk? Am J Public Health 1992, 82:614-615.
29. Thompson SC, Jolley D, Marks R: Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993, 329:1147-1151.
30. Ley RD, Applegate LA, Padilla RS, Stuart TD: Ultraviolet radiation-induced malignant melanoma in Monodelphis domestics. Photochem Photobiol 1989, 50:1-5.
31. Romerdahl CA, Stephens LC, Bucana C, Kripke ML: The role of ultraviolet radiation in the induction of melanocytic skin tumors in inbred mice. Cancer Commun 1989, 1:209-216.
32. Setlow RB, Grist E, Thompson K, Woodhead AD: Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci 1993, 90:6666-6670.
33. Klein-Szanto AJP, Silvers WK, Mintz B: Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice. Cancer Res 1994, 54:4569-4572. This new mouse model provides an opportunity to determine the melanoma action spectrum, characterize at the molecular level the melanomas induced by ultraviolet light in comparison with those of other origins, and to investigate in vivo the photoprotective role of melanin.
34. Larue L, Dougherty N, Mintz F: Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal malanocytes. Proc Natl Acad Sci 1992, 89:9534-9538.
35. Donawho CK, Wolf P, Kripke ML: Enhanced development of murine melanoma in UV-irradiated skin: UV dose response, waveband dependence, and relation to inflammation. Melanoma Res 1994, 4:93-100.
36. Drobetsky EA, Torcotte J, Chateauneuf A: A role for ultraviolet A in solar mutagenesis. Proc Natl Acad Sci 1995, 92:2350-2354.
37. Ahmed FE, Setlow RB: Ultraviolet radiation-induced DNA damage and its photorepair in the skin of the Platyfish Xiphophorus. Cancer Res 1993, 53:2249-2255.
38. Setlow RB, Woodhead AD: Temporal changes in the incidence of malignant melanoma: explanation from action spectra. Mut Res 1994, 307:365-374. Certain fish (Xiphophorus) are very sensitive to light-induced melanomas; the investigators have used them to determine the action spectrum effective in melanoma induction and found a very large component in the ultraviolet A region (320-400nm).
39. Mukherji B, Chakraborty NG: Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 1995, 7:175-184. The immunobiology of melanoma has dominated the investigative field in tumor immunology. The best evidence of immunogenicity of a spontaneously grown human cancer has been found in this model.
40. Streilein JW, Taylor JR, Vincek V, Kurimoto I, Shimizu T, Tie C, Golomb C: Immune surveillance and sunlight-induced skin cancer. Immunol Today 1994, 15:174-179. The authors reviewed the effects of ultraviolet B radiation on the induction of cutaneous immunity in the skin of mice and humans.
41. Saijo S, Bucana CD, Ramirez KM, Coz PA, Kripke ML, Strickland FM: Deficient antigen presentation and Ts induction are separate effects of ultraviolet irradiation. Cell Immunol 1995, 164:189-202. Ultraviolet-B irradiation of murine skin results in immunosuppressive effects on more than one cellular component in the host. Effects on APCs contribute to deficient induction of immune responses within the ultraviolet-irradiated site. Soluble mediators induced in response to ultraviolet radiation contribute to the induction of T cells that mediate transferable suppression.
42. Shimizu T, Streilein JW: Evidence that ultraviolet B radiation induces tolerance and impairs induction of contact hypersensitivity by different mechanisms. Immunology 1994, 82:140-148. The authors data supports the view that the generation of suppressor cells and the development of hapten-specific tolerance may be mechanistically distinct.
43. Kraemer KH, Lee M, Andrews AD, Lambert WC: The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: the xeroderma pigmentosum paradigm. Arch Dermatol 1994, 130:1018-1021. The frequency of melanomas was increased 1000-fold or more in XP patients younger than 20 years of age. The site distribution of melanoma and non-melanoma skin cancers was like the general population, with a higher proportion of face, head, or neck and a lower proportion on the trunk, particularly in males. The data suggests that DNA repair plays a major role in the prevention of skin cancers in the general population, and that sunlight exposure is responsible for the development of melanoma as well as nonmelanoma skin cancers in patients with XP, although different mechanisms may be involved for the two types of skin cancers.
44. Thielmann HW, Popanda O, Edler L, Böing A, Jung EG: DNA repair synthesis following irradiation with 254-nm and 312-nm ultraviolet light is not diminished in fibroblasts from patients with dysplastic nevus syndrome. J Cancer Res Clin Oncol 1995, 121:327-337. The investigators examined the hypothesis that patients with dysplastic nevus syndrome are prone to melanoma development because of a general defect in post-ultraviolet DNA repair and find this hypothesis to be improbable.
45. Kripke ML: Response [letter]. J Natl Cancer Inst 1994, 86:799.
46. Kligman LH, Akin FJ, Kligman AM: Prevention of ultraviolet damage to the dermis of hairless mice by sunscreens. J Invest Dermatol 1982, 78:181-189.
47. Kligman LH, Akin FJ, Kligman AM: Sunscreens prevent ultraviolet photocarcinogenesis. J Am Acad Dermatol 1980, 3:30-35.
48. Synder DS, May M: Ability of PABA to protect mammalian skin from ultraviolet light-induced skin tumors and actinic damage. J Invest Dermatol 1975, 65:543-546.
49. Naylor MF, Boyd A, Smith WW, Cameron GS, Hubbard D, Neldner KH: High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995, 131:170-175. In this prospective, double-blind placebo-controlled trial for a 2-year period the daily application of a sun protection factor 29 sunscreen significantly reduced the number of solar keratoses by 51%.
50. Hunter DJ, Colditz GA, Stampfer MJ, Kosner B, Willet WC, Speizer FE: Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1990, 1:13-23.
51. Wolf P, Yarosh DB, Kripke ML: Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J Invest Dermatol 1993, 101:523-527.
52. Wolf P, Donawho CK, Kripke ML: Effect of sunscreens on UV-radiation-induced enhancement of melanoma growth in mice. J Natl Cancer Inst 1994, 86:99-105.
53. Bestak R, Barnetson RSC, Nearn MR, Halliday GM: Sunscreen protection of contact hypersensitivity responses from chronic solar-simulated ultraviolet irradiation correlates with the absorption spectrum of the sunscreen. J Invest Dermatol 1995, 105:345-351. Various sunscreens offered minimal protection against local and systemic suppression on contact hypersensitivity in mice after chronic treatment with suberythemal, solar-simulated ultraviolet radiation. The most effective sunscreen had immunoprotective factors between 1 and 1.13, whereas their sun protection factor for mice was 4.0 and 7.0. respectively.
54. Whitemore SE, Morison WL: Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen. Archiv Dermatol 1995, 131:1128-1133. A sunscreen (sun protection factor 29) protected human volunteers from local suppression of contact hypersensitivity to dinitro-chlorobenzene, produced by three consecutive ultraviolet exposures of three minimal erythemal doses each.
55. Granstein RO: Evidence that sunscreens prevent UV radiation-induced immunosuppression inhuman. Arch Dermatol 1995, 131:1201-1204.
56. Roberts LD, Beasley DG: Commercial sunscreen lotions prevent ultraviolet radiation-induced immune suppression of contact hypersensitivity. J Invest Dermatol 1995, 105:339-344. Commercial sunscreens protected mice from local suppression of contact hypersensitivity by two consecutive exposures to ultraviolet radiation, particularly when solar-simulated ultraviolet radiation was used.
57. Mersey P, MacDonald M, Burns C, Schibeci S, Matthews H, Wilkinson FJ: Analysis of the effect of a sunscreen agent on the suppression of natural killer cell activity induced in human subjects by radiation from solarium lamps. J Invest Dermatol 1987, 88:271-276.